Is Summit Therapeutics (SMMT) Still Attractive After Recent Pullback And Multi Year Surge [Yahoo! Finance]
Summit Therapeutics Inc. (SMMT)
Last summit therapeutics inc. earnings: 6/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
summitplc.com/investors/investor-centre
Company Research
Source: Yahoo! Finance
The stock is trading at US$17.04, with a 1 year return of 2.3% and a very large 3 year gain that is around 3x, even after an 8.7% decline over the last week and a 3.0% decline over the last month. These recent moves may have shifted how the market is pricing risk and potential. Recent attention on Summit Therapeutics has been driven by ongoing interest in its drug development pipeline and how investors view the company within the broader pharmaceuticals and biotech space. These factors help frame why the stock has experienced both strong multi year gains and short term pullbacks. Simply Wall St currently gives Summit Therapeutics a value score of 2 out of 6 , based on how many of its valuation checks screen as undervalued. Next we will look at what different valuation methods say about the stock, and then finish with a way to think about valuation that many investors find even more useful. Summit Therapeutics scores just 2/6 on our valuation checks. See what other red flags we
Show less
Read more
Impact Snapshot
Event Time:
SMMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SMMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SMMT alerts
High impacting Summit Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
SMMT
News
- Summit Therapeutics (NASDAQ:SMMT) was given a new $40.00 price target on by analysts at Piper Sandler.MarketBeat
- Summit Therapeutics (NASDAQ:SMMT) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Summit Therapeutics (SMMT) Is Down 8.7% After Ivonescimab BLA Filing And Oncology Expansion Update – Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
- 2 Biotech Stocks That Could Soar This Year [Yahoo! Finance]Yahoo! Finance
- Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate (ADC) [Yahoo! Finance]Yahoo! Finance
SMMT
Earnings
- 10/20/25 - Beat
SMMT
Sec Filings
- 1/12/26 - Form 4
- 1/12/26 - Form 8-K
- 1/6/26 - Form 4
- SMMT's page on the SEC website